Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "interventions"

182 News Found

Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement
Healthcare | July 05, 2022

Apollo Hospitals Navi Mumbai performs first minimally invasive mitral heart valve replacement

Transcatheter Mitral valve procedure allows intervention on patients who are unsuitable or high risk for open heart surgery


NITI Aayog releases a compendium of Ayush-based practices
News | July 02, 2022

NITI Aayog releases a compendium of Ayush-based practices

The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.


EPR-Technologies announces new approach to emergency care when CPR fails
Healthcare | June 16, 2022

EPR-Technologies announces new approach to emergency care when CPR fails

EPR-Technologies is pursuing development of an unprecedented standard of emergency care when CPR fails


Merck and Ridgeback announce new data for investigational molnupiravir
News | June 08, 2022

Merck and Ridgeback announce new data for investigational molnupiravir

Based on a post hoc analysis, fewer required respiratory interventions


Digitalization of pharma labs will help in better decision making: Experts
Digitisation | June 02, 2022

Digitalization of pharma labs will help in better decision making: Experts

Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth


CorePath partners with Cizzle Bio to develop blood test to detect lung cancer
Biotech | May 27, 2022

CorePath partners with Cizzle Bio to develop blood test to detect lung cancer

Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths


50% of the world's population expected to be myopic by 2050
News | May 23, 2022

50% of the world's population expected to be myopic by 2050

Researchers have found out that myopia often leads to an abnormal increase in axial length. When the axial length grows to more than 25mm, especially with age, problems like cataracts or glaucoma can appear


Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders
Biotech | May 20, 2022

Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders

First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm


Cytel designed and led TOGETHER trial wins Clinical Trial award
News | May 18, 2022

Cytel designed and led TOGETHER trial wins Clinical Trial award

Leading this effort was Cytel’s principal research scientist and Professor of Health Research Methods at McMaster University in Canada, Dr. Edward Mills


Hetero unveils new logo and corporate brand identity
News | May 11, 2022

Hetero unveils new logo and corporate brand identity

The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version